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IMPORTANCE Sexual harassment and sexual assault are prevalent experiences among
women. However, their association with health indices is less well understood.
OBJECTIVE To investigate the association of history of sexual harassment and sexual assault
with blood pressure, mood, anxiety, and sleep amongmidlife women.
DESIGN, SETTING, AND PARTICIPANTS Nonsmokingwomenwithout cardiovascular disease
were recruited from the community to undergo physical measurements (blood pressure,
height, weight), medical history, and questionnaire psychosocial assessments (workplace
sexual harassment, sexual assault, depression, anxiety, sleep).
EXPOSURES Sexual harassment and sexual assault.
MAIN OUTCOMES ANDMEASURES Blood pressure, depressive symptoms, anxiety, and sleep
characteristics.
RESULTS Among the 304 nonsmoking women aged 40 to 60 years who participated in the
study, all were free of clinical cardiovascular disease, and themean (SD) age was 54.05 (3.99)
years. A total of 19% reported a history of workplace sexual harassment (n = 58), and 22%
reported a history of sexual assault (n = 67). Sexual harassment was related to significantly
greater odds of stage 1 or 2 hypertension among women not taking antihypertensives (odds
ratio [OR], 2.36; 95% CI, 1.10-5.06; P = .03) as well as clinically poor sleep (OR, 1.89; 95% CI,
1.05-3.42; P = .03), after adjusting for covariates. Sexual assault was associated with
significantly greater odds of clinically elevated depressive symptoms (OR, 2.86; 95% CI,
1.42-5.77; multivariable P = .003), clinically relevant anxiety (OR, 2.26; 95% CI, 1.26-4.06;
P = .006), and clinically poor sleep (OR, 2.15; 95% CI, 1.23-3.77; multivariable P = .007), after
adjusting for covariates.
CONCLUSIONS AND RELEVANCE Sexual harassment and sexual assault are prevalent
experiences amongmidlife women. Sexual harassment was associated with higher blood
pressure and poorer sleep. Sexual assault was associated with poorer mental health and
sleep. Efforts to improve women’s health should target sexual harassment and assault
prevention.
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S exual harassment and sexual assault are common ex-periences among women. In the United States, an esti-mated 40% to 75% of women have experienced work-
place sexual harassment,1 and over 1 in 3 women (36%) have
experienced sexual assault.2 With recent popular move-
ments (eg, MeToo, #TimesUp), there is rising public aware-
ness of sexual harassment and assault and their implications
for women’s health.
Both sexual harassment and sexual assault have been
linked to poorer self-reported physical and mental health
outcomes.3-8While these studies suggest thatharassment and
assault are associated with adverse outcomes broadly, these
findings are limitedby several issues. Survey studies, particu-
larly of sexual harassment, largely assess physical health via
self-report.These reports canbebiasedbymood,memory, and
reporting of physical symptoms9 and by awareness of health
conditions, which can vary by socioeconomic status, health
care access, andhealth literacy.10Another limitation is incom-
plete consideration of critical confounding factors, such as
socioeconomic position, adiposity, and medication use. Fur-
thermore, self-reported outcomes are often assessed using
single-question items rather than full validatedmeasures. Re-
searchonsexualharassmentandassaultusingmeasuredhealth
indices, fullmultidimensional scales, andcomprehensivecon-
sideration of confounders is warranted.
Amongawell-characterizedsampleof304midlifewomen,
we investigated the association of a history of sexual harass-
ment and sexual assault with blood pressure (BP), depressed
mood, anxiety, and sleep, important health issues affecting
midlife women. Elevated BP is a major risk factor for cardio-
vasculardisease (CVD), the leading causeofdeath inwomen,11
and an important indicator of risk amongmidlifewomenwho
typically develop clinical CVD later in life.12 Depression and
anxiety show a doubling in rates in women relative to men,13
anduptohalfofmidlifewomenreportproblemswithsleep.14,15
We hypothesized that sexual harassment and assault would
be associatedwithhigherBP,moredepressedmoodandanxi-
ety, and poorer sleep after accounting for key confounders.
Methods
Study Participants
A total of 304 nonsmoking women aged 40 to 60 years
were recruited from the community (Pittsburgh, Pennsylva-
nia) via advertisements,mailings, andonlinemessageboards.
The cohort was originally selected for a study designed to ex-
amine the associationofmenopausal hot flashes and subclini-
cal atherosclerosis as assessed by carotid ultrasonography.16
Per the original study design, half of the women reported
menopausal hot flashes, andhalf reportednohot flashes.16Of
the 1929 women who underwent telephone screening, 304
were eligible andenrolled. Exclusions, selectedbasedon their
impact onmenopausal symptoms and cardiovascular health,
included premenopausal status; hysterectomy or oophorec-
tomy; reportedhistoryofCVD, arrhythmia, kidney failure, gy-
necological cancer; current pregnancy; or having used key
medications in the past 3 months: oral/transdermal estrogen
or progesterone, selective estrogen receptor modulators, se-
lective serotonin reuptake inhibitors, serotonin norepineph-
rine reuptake inhibitors, gabapentin, insulin, β-blockers,
calcium channel blockers, and α-2 adrenergic agonists. Pro-
cedures were approved by the University of Pittsburgh insti-
tutional review board, and all participants provided written
informed consent.
Main Outcomes andMeasures
Procedures includedphysicalmeasurements, interviews, and
questionnaires. Sexual harassment and assault were as-
sessed fromBrief TraumaQuestionnaire items developed for
the Nurses’ Health Study II17 adapted from the Brief Trauma
Interview.18,19 Items assessed workplace sexual harassment
(“Have you ever experienced sexual harassment at work that
was either physical or verbal?”) and sexual assault (“Haveyou
ever been made or pressured into having some type of un-
wanted sexual contact? [By sexual contact wemean any con-
tact between someone else and your private parts or between
youandsomeoneelse’sprivateparts])?”Responseoptionswere
yes/no. Thismeasure has high interrater reliability relative to
theDiagnosticandStatisticalManualofMentalDisorders (fourth
edition) for presence of Criterion A1 trauma exposure
(κ = 0.70).17
Seated BP was measured via a Dinamap device after a
10-minute rest. Height and weight were measured via a sta-
diometer andbalancebeamscale. Bodymass index (BMI)was
calculated asweight in kilograms divided by height inmeters
squared. Depressive symptoms were assessed by the Center
forEpidemiologicStudiesDepression (CESD)scale,20 trait anxi-
ety via the Spielberger State-Trait Anxiety Inventory (STAI),21
andsleepqualityvia thePittsburghSleepQuality Index(PSQI)22
considered continuously and via clinical cut points (CESD
≥1620; PSQI >522; and STAI ≥4023 and upper quartile of nor-
mative samples21).Demographicsandmedicalhistorywereas-
sessedviastructured interview.Womenreportedcurrentmedi-
cation use (eg, for BP: angiotensin converting enzyme
inhibitors, angiotensin receptor blockers, diuretics; for sleep:
melatonin, GABA-α agents (γ-aminobutyric acid-α); for anxi-
ety: benzodiazepines; and for depression: bupropion, tricy-
clic agents). Physical activity was assessed via the Interna-
Key Points
Question Dowomenwith a history of sexual harassment or
sexual assault have higher blood pressure, greater depression and
anxiety, and poorer sleep than womenwithout this history?
Findings Among 304 nonsmokingmidlife women recruited from
the community to undergo assessment and complete
questionnaires for this prospective cohort study, those with a
history of workplace sexual harassment had significantly higher
odds of hypertension and clinically poor sleep than women
without this history, after adjusting for covariates. Womenwith a
history of sexual assault had significantly higher odds of clinically
significant depressive symptoms, anxiety, and poor sleep than
womenwithout this history, after adjusting for covariates.
Meaning Sexual harassment and sexual assault have implications
for women’s health.
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tional Physical Activity Questionnaire24 and snoring via the
Berlin Questionnaire.25
Data Analyses
All PSQI valueswere natural log–transformed for analysis. Dif-
ferencesbetweenparticipantsbyharassmentorassaulthistory
were testedusing linear regression,Wilcoxon rank sum,andχ2
tests.Associationsbetweenexposuresandoutcomesweretested
inregressionmodels.Covariateswerefactorsassociatedwiththe
outcomeatP < .15,with select variables selectedapriori for in-
clusion(medicationsandforsleepmodelssnoringandnightshift
work).Residualanalysisanddiagnosticplotswereconductedto
verifymodel assumptions.Analyseswereperformedwith SAS
software, version 9.4 (SAS Institute Inc). Models were 2 sided,
α = .05.
Results
Participants were on average 54 years old (Table 1). Nineteen
percent of women (n = 58) reported a history of workplace
sexual harassment, and 22% reported a history of sexual as-
sault (n = 67). Tenpercent ofwomen reportedboth sexual ha-
rassment andassault (n = 30).Womenwith ahistoryof sexual
harassmenthadhigher educationyetmore financial strain.No
characteristics varied by sexual assault.
Women with a history of sexual harassment had signifi-
cantly higher systolic BP (SBP),marginally higher diastolic BP
(DBP), andsignificantlypoorer sleepquality thanwomenwith-
out a history of harassment, after adjusting for covariates (all
supportingdata provided inTable 2).When considering clini-
cal cut points, harassment was associated with significantly
higher likelihood of stage 1 or 2 hypertension among women
not takingantihypertensivemedications (SBP≥130orDBP≥80
mm Hg; odds ratio [OR], 2.36; 95% CI, 1.10-5.06; multivari-
ableP = .03) and of poor sleep consistentwith clinical insom-
nia (OR, 1.89; 95% CI, 1.05-3.42; multivariable P = .03)
(Figure 1).
Womenwithahistoryof sexual assault hadhigherdepres-
sive symptoms, anxiety, andpoorer sleepquality thanwomen
without a history of sexual assault (Table 2). Assault was as-
sociated with significantly higher odds of clinically elevated
depressive symptoms (OR, 2.86; 95%CI, 1.42-5.77;multivari-
able P = .003), anxiety (OR, 2.26; 95% CI, 1.26-4.06; multi-
variable P = .006), and poor sleep (OR, 2.15; 95% CI, 1.23-
3.77; multivariable P = .007) (Figure 2).
Table 1. Study Participant Characteristics
Characteristic
Participants, No. (%) (n = 304)
Workplace Sexual Harassment Sexual Assault
Yes (n = 58
[19%])
No (n = 246
[81%])
Yes (n = 67
[22%])
No (n = 237
[78%])
Age, mean (SD), y 53.93 (3.53) 54.08 (4.09) 53.73 (4.06) 54.14 (3.97)
Race/ethnicity
White 45 (77.59) 175 (71.14) 50 (74.63) 170 (71.73)
Nonwhitea 13 (22.41) 71 (28.86) 17 (25.37) 67 (28.27)
Educationb
<College 17 (29.31) 112 (45.53) 23 (34.33) 106 (44.73)
≥College 41 (70.69) 134 (54.47) 44 (65.67) 131 (55.27)
Marital status
Married/partnered 28 (48.28) 142 (57.72) 32 (47.76) 138 (58.23)
Divorced/widowed 14 (24.14) 64 (26.02) 17 (25.37) 61 (25.74)
Single 16 (27.59) 40 (16.26) 18 (26.87) 38 (16.03)
Financial strain, yesc 27 (46.55) 68 (27.98) 26 (38.81) 69 (29.49)
BMI, mean (SD) 27.85 (6.07) 29.26 (6.89) 27.80 (6.20) 29.32 (6.88)
Alcohol use
<Monthly 21 (36.21) 109 (44.31) 29 (43.28) 101 (42.62)
Monthly but <weekly 20 (34.48) 77 (31.30) 23 (34.33) 74 (31.22)
Weekly 17 (29.31) 60 (24.39) 15 (22.39) 62 (26.16)
Leisure physical activity (IPAQ score),
median (IQR)d
458 (0-1286) 396 (0-1298) 297 (0-1188) 438 (0-1386)
Snoring 27 (46.55) 109 (44.31) 31 (46.27) 105 (44.30)
Nightshift work 3 (5.17) 17 (6.91) 5 (7.46) 15 (6.33)
Medication use
BP-lowering 9 (15.52) 39 (15.85) 7 (10.45) 41 (17.30)
Sleep 2 (3.45) 12 (4.88) 1 (1.49) 13 (5.49)
Antidepressants 1 (1.72) 5 (2.03) 1 (1.49) 5 (2.11)
Anxiolytics 1 (1.72) 4 (1.63) 1 (1.49) 4 (1.69)
Abbreviations: BMI, bodymass index
(calculated as weight in kilograms
divided by height in meters squared);
BP, blood pressure; IPAQ,
International Physical Activity
Questionnaire24; IQR, interquartile
range.
a Nonwhite race/ethnicity includes
African American, Asian, Hispanic,
or biracial.
b Education level varied significantly
by harassment status (P < .05).
c Financial strain was defined as
somewhat hard or very hard to pay
for basic necessities of life, and it
varied significantly by harassment
status (P < .05).
d Physical activity was square-root
transformed for analysis.
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Discussion
Among the study participants, 19% reported a history of work-
placesexualharassment,and22%reportedahistoryofsexualas-
sault. Sexual harassment was associated with higher BP and
poorer sleep, andsexual assaultwithdepressedmood, anxiety,
andpoorsleep.Associationspersistedafteradjusting fordemo-
graphic and biomedical covariates.
Approximately 1 in5womenreportedhavingbeensexually
harassed or sexually assaulted. Although high, these rates are
lower than those of national samples.1,2 Variations in estimates
canarise fromsamplecharacteristics,assessmentmethods,and
willingnessofparticipants toreport thesesensitiveexperiences.
Our samplewas somewhat lower risk in sociodemographic and
physicalcharacteristics thantheaveragepopulationbecausewe
excludedwomenwhowere smokers,whohadundergonehys-
terectomy,orwhowereusingcommonantidepressantsandcer-
taincardiovascularmedications.Fewcharacteristicsdistinguished
betweenwomenwhohadbeensexuallyharassedandthosewho
hadbeensexuallyassaulted,withtheexceptionthatwomenwho
were sexuallyharassedweremorehighly educatedyetmore fi-
nancially strained. Notably, women who are younger or are in
moreprecariousemploymentsituationsaremore likelytobeha-
rassed,andfinanciallystressedwomencanlackthefinancial se-
curity to leave abusivework situations.3Whymorehighly edu-
catedwomeninthepresentstudyweremorelikelytobeharassed
is unclear; thesewomenmaymore often be employed inmale-
dominatedsettings,bemoreknowledgeableaboutwhatconsti-
tutes sexualharassment, orbeperceivedas threatening; sexual
harassment is an assertion of hierarchical power relations.3,26
This study examines sexual harassment and assault in re-
lation to measured BP, an advance over previous work relying
largely on self-reports. An exception is work by Krieger and
colleagues,27whoexaminedworkplacehazards inrelationtoBP
among low-income participants, finding that only sexual
harassment was associated with SBP among women. Notably,
themagnitudeof increase inSBPobserved in thepresent study
associated with a history of harassment (approximately 4
mmHg in SBP) is clinically significant (eg, a 20% increased risk
forCVD).28 Importantly,harassedwomennot takingantihyper-
tensive agents hadmore than 2-fold increased odds of BP con-
sistent with hypertension.
Sexualassaultwasrelatedtopoorermentalhealth.Assaulted
womenhadalmost 3-foldgreater oddsof symptomsconsistent
with amajor depressive disorder andmore than 2-fold greater
oddsofelevatedanxiety.Conversely,sexualassaultappearedless
Figure 2. Association of Sexual AssaultWith DepressedMood, Anxiety,
and Sleep Quality
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For depressedmood, the adjusted odds ratio (aOR) was 2.86 (95% CI,
1.42-5.77) (P = .003); for anxiety, aOR, 2.26 (95% CI, 1.26-4.06) (P = .006); for
sleep, aOR, 2.15 (95% CI, 1.23-3.77) (P = .007). Depression and anxiety models
were adjusted for age, race/ethnicity, education, BMI, use of antidepressants,
and use of anxiolytics; sleepmodels were adjusted for age, race/ethnicity,
education, BMI, snoring, use of sleepmedication, and nightshift work.
Table 2.Workplace Sexual Harassment and Sexual Assault AssociatedWith BP,Mental Health, and Sleep Indicesa
Characteristic Sexual Harassment, B (SE) P Value Sexual Assault, B (SE) P Value
SBP 3.96 (1.94) .04 1.55 (1.85) .40
DBP 2.40 (1.29) .06 1.49 (1.23) .23
Depressive symptoms 2.27 (1.21) .06 4.01 (1.13) <.001
Anxiety 1.55 (1.43) .28 3.78 (1.34) .005
Sleep qualityb 0.15 (0.07) .03 0.24 (0.06) <.001
Abbreviations: BMI, bodymass index (calculated as weight in kilograms divided
by height in meters squared); BP, blood pressure; B (SE), unstandardized beta
(standard error); DBP, diastolic blood pressure; SBP, systolic blood pressure.
a All models adjusted for age, race/ethnicity, education, BMI; BPmodels
adjusted for use of BP-lowering medication; depression/anxiety models
adjusted for use of antidepressants or anxiolytics; sleepmodels adjusted for
snoring, use of sleepmedication, nightshift work.
b Sleep quality natural log transformed for analysis.
Figure 1. Association of Sexual HarassmentWith Prevalence
of Hypertension and Poor Sleep
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For hypertension, the adjusted odds ratio (aOR) was 2.36 (95% CI, 1.10-5.06)
(P = .03); for sleep, aOR, 1.89 (95% CI, 1.05-3.42) (P = .03). Hypertension
models were adjusted for age, race/ethnicity, education, and BMI among
women not using antihypertensive medications; hypertension stage 1 or 2 was
defined as systolic blood pressure of 130mmHg or higher or diastolic blood
pressure of 80mmHg or higher. Sleepmodels were adjusted for age,
race/ethnicity, education, BMI, snoring, use of sleepmedication, and
nightshift work.
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relatedtoBP;a relationthatmaydependontheseverityorchro-
nicity of the victimization history.29 Sexual assault andharass-
mentwereeachassociatedwitha2-fold increasedoddsofpoor
sleepconsistentwithclinical insomnia.Notably,poorsleep,30,31
depressedmood,32andanxiety33are themselves linkedadverse
physical health outcomes.
Strengths and Limitations
Thisworkhas limitations. Study exposureswere assessedvia 2
questions.Futureworkshoulduseafullmultidimensionalscale
thatmeasures theseverityandchronicityofexposures.Women
recalledharassmentandassaultandreportedexclusionarymedi-
calconditionsthatmayincorporatereportingbiases.Thesample
had somewhat limited representation of racial/ethnicminority
groupsand reflected several exclusions; thus, findingsmaynot
begeneralizable toallwomen.Futureworkshould includemore
diversesamples.Thiswork incorporatesmultiplecomparisons.
Finally, this study cannot establish the causality or temporality
of exposures associatedwith outcomes.
This studyhas several strengths.Weconsideredsexualha-
rassment and assault, prevalent yet understudied exposures
inwomen.We consideredmeasuredBP and a range ofmental
health indices assessed with full, validated scales. We ad-
justed for a range of key covariates.We studied these associa-
tions in a well-characterized sample of women.
Conclusions
Among midlife women, workplace sexual harassment was
associated with higher BP and poorer sleep, and sexual
assault with depressed mood, anxiety, and poorer sleep.
Future work should consider whether preventing or mitigat-
ing sexual harassment and sexual assault can improve wom-
en’s mental and cardiovascular health. Given the high
prevalence of sexual harassment and assault, addressing
these prevalent and potent social exposures may be critical
to promoting health and preventing disease in women.
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